首页> 外文OA文献 >Treatment outcomes in palliative care: the TOPCare study. A mixed methods phase III randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy
【2h】

Treatment outcomes in palliative care: the TOPCare study. A mixed methods phase III randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy

机译:姑息治疗的治疗结果:TOPCare研究。一项混合方法III期随机对照试验,评估了由护士主导的姑息治疗干预措施对HIV阳性患者进行抗逆转录病毒治疗的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Patients with HIV/AIDS on Antiretroviral Therapy (ART) suffer from physical, psychological and spiritual problems. Despite international policy explicitly stating that a multidimensional approach such as palliative care should be delivered throughout the disease trajectory and alongside treatment, the effectiveness of this approach has not been tested in ART-experienced populations.METHODS/DESIGN:This mixed methods study uses a Randomised Controlled Trial (RCT) to test the null hypothesis that receipt of palliative care in addition to standard HIV care does not affect pain compared to standard care alone. An additional qualitative component will explore the mechanism of action and participant experience. The sample size is designed to detect a statistically significant decrease in reported pain, determined by a two tailed test and a p value of [less than or equal to]0.05. Recruited patients will be adults on ART for more than one month, who report significant pain or symptoms which have lasted for more than two weeks (as measured by the African Palliative Care Association (APCA) African Palliative Outcome Scale (POS)). The intervention under trial is palliative care delivered by an existing HIV facility nurse trained to a set standard. Following an initial pilot the study will be delivered in two African countries, using two parallel independent Phase III clinical RCTs. Qualitative data will be collected from semi structured interviews and documentation from clinical encounters, to explore the experience of receiving palliative care in this context.DISCUSSION:The data provided by this study will provide evidence to inform the improvement of outcomes for people living with HIV and on ART in Africa.ClinicalTrials.gov Identifier: NCT01608802
机译:背景:抗逆转录病毒疗法(ART)的HIV / AIDS患者患有身体,心理和精神问题。尽管国际政策明确指出应在整个疾病过程中以及在治疗过程中采用姑息治疗等多维方法,但尚未在有ART经验的人群中检验这种方法的有效性。方法/设计:此混合方法研究使用了随机方法对照试验(RCT)检验了零假设,即与标准的HIV护理相比,除标准的HIV护理外,接受姑息治疗不会影响疼痛。一个额外的定性成分将探讨行动的机制和参与者的经验。样本量旨在检测统计学上报告的疼痛减轻情况,该减轻程度由两尾检验和p值[小于或等于] 0.05确定。被招募的患者将是成年人接受抗逆转录病毒治疗超过一个月的时间,他们报告持续了超过两周的严重疼痛或症状(根据非洲姑息治疗协会(APCA)非洲姑息结果量表(POS)进行测量)。接受试验的干预措施是接受培训的既定标准的现有HIV设施护士提供的姑息治疗。在最初的试验之后,该研究将使用两个平行的独立的III期临床RCT在两个非洲国家进行。定性数据将从半结构化访谈和临床遭遇中的文献中收集,以探索在这种情况下接受姑息治疗的经验。讨论:本研究提供的数据将为改善艾滋病毒和艾滋病感染者的预后提供信息。非洲抗逆转录病毒疗法研究.ClinicalTrials.gov标识符:NCT01608802

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号